Omega‐3 vs placebo
Biochemical markers of essential fatty acid status: EPA and DHA % content of neutrophil membrane · adults and children with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 29 participantsVery low
Findings
What do systematic reviews say?
6 questions · 6 findings · 1 reviews · Cystic Fibrosis and Genetic Disorders
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 6 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Omega‐3 vs placebo
Pulmonary exacerbations · adults and children with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 13 participantsVery low
Omega‐3 vs placebo
Diarrhoea · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes adverse events: diarrhoea compared with placebo (very low certainty).
1 finding from 1 review
- OR 0.6 [0.05, 6.79]1 study · 12 participantsVery low
Omega‐3 vs placebo
FEV1 % predicted · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes FEV1 % predicted compared with placebo (very low certainty).
1 finding from 1 review
- MD 2 [19.11, 23.11]1 study · 17 participantsVery low
Omega‐3 vs placebo
FVC · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes FVC % predicted compared with placebo (very low certainty).
1 finding from 1 review
- no estimate extracted1 study · 17 participantsVery low
Omega‐3 vs placebo
Z score BMI · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes growth and nutrition: BMI SD score compared with placebo (very low certainty).
1 finding from 1 review
- MD 01 study · 29 participantsVery low